PIKing up and AKTing on Resistance Mutations in Osimertinib-Treated EGFR-Mutated NSCLC. Vokes NI, Le X, Yap TA. Clin Cancer Res 2024;30:3968-3970.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vokes NI, Le X, Yap TA. PIKing up and AKTing on Resistance Mutations in Osimertinib-Treated EGFR-Mutated NSCLC. Clin Cancer Res 2024;30:3968-3970.
PMID: 39018064